Sun Pharmaceutical is introducing delayed-release pantoprazole oral suspension in a dosage strength of 40 mg. The product is the first generic of Pfizer’s Protonix oral delayed-release suspension 40 ...

SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. said Thursday the Food and Drug Administration granted it approval to market a generic version of Wyeth's Protonix tablets, 20 mg and ...

LONDON (Reuters) - The U.S. launch of two generic forms of Wyeth's ulcer drug Protonix will inevitably impact volume demand and increase pressure on prices for rival branded medicines, including ...

Generic drug maker Teva Pharmaceutical said today the company has agreed to extend its deal with Madison-based Wyeth and its partner Altana Pharma AG not to market a generic version of heartburn drug ...

NEW YORK (Reuters) - Wyeth posted slightly lower first-quarter earnings on Tuesday, hurt by the recent launch of generic forms of its Protonix ulcer drug, but surprisingly strong sales of other ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) reported today that its Wyeth subsidiary has reached an agreement in principle to resolve claims alleging that Wyeth’s practices relating to the ...